Is combined use of SSRIs and NSAIDs associated with an increased risk of starting peptic ulcer treatment?

Br J Clin Pharmacol. 2014 Jul;78(1):192-3. doi: 10.1111/bcp.12300.

Authors

Koen B Pouwels¹, Gerard A Kalkman, Daan Schagen, Sipke T Visser, Eelko Hak

Affiliation

¹ Unit of PharmacoEpidemiology and PharmacoEconomics (PE), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Antidepressive Agents, Tricyclic / administration & dosage
Antidepressive Agents, Tricyclic / adverse effects*
Databases, Pharmaceutical
Drug Therapy, Combination / adverse effects*
Humans
Models, Biological
Peptic Ulcer / chemically induced*
Pharmacoepidemiology / methods
Selective Serotonin Reuptake Inhibitors / administration & dosage
Selective Serotonin Reuptake Inhibitors / adverse effects*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents, Tricyclic
Serotonin Uptake Inhibitors